EXTRAPHARM HUY
ActiveSummary
The annual accounts of EXTRAPHARM HUY for financial year 2025 show a net loss of 88% of the equity at the start of that year. The 2025 annual accounts show equity of €17,633 and a net result of -€124,683. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 13% of 5,039 sector peers (NACE 47, financial year 2025). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 1.2% (low).
Overview
Official details
Source: KBO- Status
- Active since 04-12-2012 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.215.594.915 4500 Huy, since 01-01-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 09-09-2025
Board and ownership
- VAN SULL FrançoisDirector
- VSF MANAGEMENT100%2025 annual accounts of VSF MANAGEMENT
- SAARBACH DINO49%2023 annual accounts of SAARBACH DINO
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.2%
- Gross margin
- €240,405
- ▼ 22.3%
- Turnover
- ≈ €1.1m
- estimated
- Loss
- €124,683
- Equity
- €17,633
- ▼ 87.6%
- Total assets
- €2.4m
- ▲ 94.2%
- Employees on 31-12-2025
- 5
- ▲ 150%
Score breakdownraises riskCapped at 59: a net loss of at least half of total assets or of the equity at the start of the financial yearEquity €17,633 (0.7% of total assets)Loss of €124,683 (financial year 2025)Sector: Retail trade (NACE 47)lowers riskFounded in 2012Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 20% of them on solvency, 35% on liquidity, 21% on profitability and 6% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 78 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Equity fell in 2025from €142,316 to €17,633 ▼ 87.6% View
- Caution: Lower net result than 90% of companies in retail tradesector median €40,073 · 5,038 companies -€124,683 View
- Caution: Board changedlatest change 07-08-2026 · 1 in office 1 joined · 1 left View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
Recent changes
- · Gazette deed 1 director appointed, 1 director resigningPermanent representatives: FIEY Roel and VAN SULL François · Resignation: VSF Management SRL (administrateur au nom et pour le compte de vsf management srl) · Appointment: VAN SULL François (administrateur au nom et pour le compte de vsf management srl)
- · Gazette deed Company renamed to EXTRAPHARM HUY
- · Gazette deed Resignation: SAARBACH DINO SRL (director)Permanent representatives: SAARBACH Dino and FIEY Roel
Comparable companies
These companies have the same main activity as EXTRAPHARM HUY: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.6m and €2.6m, founded between 2003 and 2017.
| Company | Total assets | Gross margin |
|---|---|---|
| EXTRAPHARM HUY Huy | €2.4m | €0.2m |
| Apotheek Kortessem Hasselt | €1.9m | €0.3m |
| PHARMACIE DU VAL DE SAMBRE Le Roeulx | €1.6m | €0.4m |
| PHARMACIE DES SAULES Frameries | €1.8m | €0.4m |
| Pharmacie T. WONNER Hamoir | €2.6m | €0.5m |
| PHARMACIE TASQUIN Dison | €1.9m | €0.4m |
| PHARMACIE BIA Hamoir | €2.1m | €0.4m |
Key facts about EXTRAPHARM HUY
- What is the company number of EXTRAPHARM HUY?
- The company number of EXTRAPHARM HUY is 0501.734.082. The VAT number is the same number with BE in front: BE 0501.734.082.
- Where is EXTRAPHARM HUY based?
- The registered office is at Quai d'Arona 9, 4500 Huy.Company details
- What does EXTRAPHARM HUY do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of EXTRAPHARM HUY?
- The legal form of EXTRAPHARM HUY is Private limited company (BV).
- When was EXTRAPHARM HUY founded?
- EXTRAPHARM HUY was founded on 04-12-2012.
- Is EXTRAPHARM HUY still active?
- Yes, EXTRAPHARM HUY is an active enterprise in the KBO register.
- How many employees does EXTRAPHARM HUY have?
- EXTRAPHARM HUY had an average of 4.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does EXTRAPHARM HUY fall under?
- In its 2025 annual accounts, EXTRAPHARM HUY states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of EXTRAPHARM HUY?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €240,405 and 51 comparable companies (NACE 477). It probably lies between €760,000 and €2.2m.
- Is EXTRAPHARM HUY profitable?
- In financial year 2025, EXTRAPHARM HUY made a loss of €124,683.
- Where can I find the annual accounts of EXTRAPHARM HUY?
- EXTRAPHARM HUY filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of EXTRAPHARM HUY due?
- EXTRAPHARM HUY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.